STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] TENET HEALTHCARE CORP Insider Trading Activity

Tenet Healthcare (NYSE: THC) CEO unloads 100K shares in two-day sale

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) reported that CEO and director Saumya Sutaria sold a total of 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026. The sales occurred at weighted-average prices with trade ranges between $272.65 and $279.14 per share, and detailed price breakdowns are available upon request.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Sutaria Saumya
Role CEO
Sold 100,000 shs ($27.64M)
Type Security Shares Price Value
Sale Common Stock F2, F4 17,220 $273.34 $4.71M
Sale Common Stock F2, F5 24,881 $274.10 $6.82M
Sale Common Stock F2, F6 7,899 $275.26 $2.17M
Sale Common Stock F1, F2 13,344 $278.17 $3.71M
Sale Common Stock F2, F3 36,656 $278.90 $10.22M
Holdings After Transaction: Common Stock — 433,564 shares (Direct)
Footnotes (6)
  1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
  2. F2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. F3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
  4. F4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
  5. F5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
  6. F6. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.
Total shares sold 100,000 shares of Common Stock Aggregate across all reported sales on 2026-08-24 and 2026-08-25
Shares sold 2026-08-24 at $278.17 13,344 shares at $278.1700 per share Weighted-average sales price; trades ranged from $277.58 to $278.57
Shares sold 2026-08-24 at $278.90 36,656 shares at $278.9000 per share Weighted-average sales price; trades ranged from $278.59 to $279.14
Shares sold 2026-08-25 at $273.34 17,220 shares at $273.3400 per share Weighted-average sales price; trades ranged from $272.65 to $273.64
Shares sold 2026-08-25 at $274.10 24,881 shares at $274.1000 per share Weighted-average sales price; trades ranged from $273.65 to $274.64
Shares sold 2026-08-25 at $275.26 7,899 shares at $275.2600 per share Weighted-average sales price; trades ranged from $274.73 to $275.55
weighted average sales price financial
"The price is the weighted average sales price of the aggregate number"
open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did THC disclose for CEO Saumya Sutaria?
THC disclosed that CEO Saumya Sutaria sold 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026, at weighted-average prices within ranges of $272.65–$279.14 per share.

On what dates did the THC CEO’s share sales occur and how many shares each day?
Saumya Sutaria sold shares on August 24, 2026 and August 25, 2026. On August 24, sales totaled 50,000 shares; on August 25, sales also totaled 50,000 shares, for an aggregate of 100,000 shares of THC common stock.

What were the reported weighted-average sale prices for the THC CEO’s transactions?
Reported weighted-average prices per share were $278.17 and $278.90 on August 24, 2026, and $273.34, $274.10, and $275.26 on August 25, 2026. Each corresponds to multiple trades within stated price ranges from $272.65 to $279.14.

How many THC shares did the CEO sell at each reported price level?
Saumya Sutaria sold 13,344 shares at $278.17, 36,656 shares at $278.90, 17,220 shares at $273.34, 24,881 shares at $274.10, and 7,899 shares at $275.26. All are weighted-average prices over multiple trades.

Were the THC CEO’s August 2026 sales made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the August 24–25, 2026 sales were made pursuant to a Rule 10b5-1 trading plan.

Does the filing state the CEO’s THC share holdings after these sales?
No post-transaction share balance is reported for these trades. The Form 4 entries for each sale list the shares sold and prices but leave the “shares following transaction” field blank.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sutaria Saumya
(Last)(First)(Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TEXAS 75254
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/24/2026S13,344D$278.17(1)(2)520,220D
Common Stock08/24/2026S36,656D$278.9(2)(3)483,564D
Common Stock08/25/2026S17,220D$273.34(2)(4)466,344D
Common Stock08/25/2026S24,881D$274.1(2)(5)441,463D
Common Stock08/25/2026S7,899D$275.26(2)(6)433,564D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
2. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
4. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
6. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.
Chad J. Wiener as Attorney-in-Fact for Saumya Sutaria08/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR